Skip to main content

Advertisement

Log in

The organization and financing of end-stage renal disease treatment in Japan

  • Published:
International Journal of Health Care Finance and Economics Aims and scope Submit manuscript

Abstract

End-stage renal disease (ESRD) affects 230,000 Japanese, with about 36,000 cases diagnosed each year. Recent increases in ESRD incidence are attributed mainly to increases in diabetes and a rapidly aging population. Renal transplantation is rare in Japan. In private dialysis clinics, the majority of treatment costs are paid as fixed fees per session and the rest are fee for service. Payments for hospital-based dialysis are either fee-for-service or diagnosis-related. Dialysis is widely available, but reimbursement rates have recently been reduced. Clinical outcomes of dialysis are better in Japan than in other countries, but this may change given recent ESRD cost containment policies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Asai A., Fukuhara S., Lo B. (1995). Attitude of Japanese and Japanese American physicians toward life sustaining treatment. Lancet 346:356–359

    Article  Google Scholar 

  • Dor, A., Pauly, M. V., Eichleay, M. A., & Held, P. J. (2007). End stage renal disease and economic incentives: The International Study of Health Care Organization and Financing (ISHCOF). International Journal of Health Financing and Economics, DOI: 10.1007/s10754-007-9024-9

  • Fukuhara S., Lopes A.A., Bragg-Gresham J.L., Kurokawa K., Mapes D.L., Akizawa T., Bommer J., Canaud B.J., Port F.K., Held P.J. (2003). Health-related quality of life among dialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study. Kidney International 64:1903–1910

    Article  Google Scholar 

  • Hidai H. (2000). Need for an incentive-based reimbursement policy toward quality of care for dialysis care for dialysis patient management. Kidney International 58:363–373

    Article  Google Scholar 

  • Hirth, R. A. (2007). The organization and financing of dialysis and kidney transplant care in the United States of America. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9019-6.

  • Iglehart J.K. (1988). Japan’s medical care system—part two. New England Journal of Medicine 319:1166–1172

    Article  Google Scholar 

  • Ikegami N. (1991). Japanese health care: low cost through regulated fees. Health Affairs 10(3):87–109

    Article  Google Scholar 

  • Ikegami N., Campbell J.C. (1995). Medical care in Japan. New England Journal of Medicine 333:1295–1299

    Article  Google Scholar 

  • Japanese Diet (1997). Organ Transplantation Act [in Japanese]. July 16, 1997.

  • Japan Renal Transplantation Society (2003). Renal transplantation: A clinical registration count report 2003 (a follow-up survey) [in Japanese]. Transplant, 4(4), 362–368.

    Google Scholar 

  • Japanese Society for Dialysis Therapy (JSDT) (1999). An overview of regular dialysis treatment in Japan (as of December 31, 1997) [in Japanese]. Tokyo: Japanese Society for Dialysis Therapy.

  • Japanese Society for Dialysis Therapy (JSDT) (2002). An overview of regular dialysis treatment in Japan (as of December 31, 2000) [in Japanese]. Tokyo: Japanese Society for Dialysis Therapy.

  • Japanese Society for Dialysis Therapy (JSDT) (2005). An overview of regular dialysis treatment in Japan (as of December 31, 2003) [in Japanese]. Tokyo: Japanese Society for Dialysis Therapy.

  • Japanese Society for Dialysis Therapy (JSDT) (2006). An overview of regular dialysis treatment in Japan (as of December 31, 2004)[in Japanese]. Tokyo: Japanese Society for Dialysis Therapy [CD Rom].

  • Japanese Society for Dialysis Therapy (JSDT) (2007). An overview of regular dialysis treatment in Japan (as of December 31, 2005) [in Japanese]. Tokyo: Japanese Society for Dialysis Therapy. Retrieved March 9, 2007, at http://www.jsdt.or.jp/overview/index.html

  • Japanese Society for Transplantation (2006). Factbook of organ transplantation in Japan, 2006 [in Japanese]. Retrieved May 22, 2007, at http://www.asas.or.jp/jst/factbook/2006/fact06_03.html

  • Lee H., Manns B.J., Taub K., Ghali W., Dean S., Johnson D., Donaldson C. (2002). Cost analysis of ongoing care of patients with end-stage renal disease: The impact of dialysis modality and dialysis access. American Journal of Kidney Diseases 40: 611–622

    Article  Google Scholar 

  • Ministry of Health, Labour and Welfare (MHLW) (2000). National medical care expenditure 1998 [in Japanese]. Tokyo: Welfare Statistics Association.

  • MHLW (1993, 1996, 1999, 2002a). Patient Survey [in Japanese]. Tokyo: Welfare Statistics Association.

  • MHLW (2002b). National Diabetes Survey [in Japanese]. Retrieved May 22, 2007, at http://www.mhlw.go.jp.

  • MHLW (2004). National medical care expenditure 2002 [in Japanese]. Tokyo: Welfare Statistics Association.

  • National Institute of Population and Social Security Research (NIPSSR). (2002). Population projections for Japan: 2001–2050. Tokyo: National Institute of Population and Social Security Research.

  • Oliver A.J., Ikegami N., Ikeda S. (1997). Japan’s aging population; implication for health care. Pharmacoeconomics 11:306–318

    Article  Google Scholar 

  • OECD (2005). OECD health data 2005. Paris: Organization for Economic Co-operation and Development.

  • OECD (2006). Purchasing power parities (PPPs) for OECD Countries 1980–2005. Paris: Organization for Economic Cooperation and Development. Retrieved April 28, 2006, at http://www.oecd.org/dataoecd/61/56/1876133.xls

  • OECD (2007). OECD statistical profile for Japan – 2006. OECD Statistics v.4.3. Retrieved May 21, 2007, at, http://stats.oecd.org/wbos/viewhtml.aspx?query name=321&querytype=view&lang=en

  • Pisoni R.L., Bragg-Gresham J., Young E.W., Akizawa T., Asano Y., Locatelli F., Bommer J., Cruz J.M., Kerr P.G., Mendelssohn D.C., Held P.J., Port F.K. (2004). Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). American Journal of Kidney Diseases 44:94–111

    Article  Google Scholar 

  • Saran R., Bragg-Gresham J.L., Wizemann V., Twardowski Z., Saito A., Levi N.W., Kimata N., Gillespie B.W., Combe C., Bommer J., Akiba T., Young E.W., Port F.K. (2006). Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney International 69:1222–1228

    Article  Google Scholar 

  • Sugisaki H., Suzuki M., Yoshida T., Yamazaki C. (2004). Ground-design in hemodialysis therapy [in Japanese]. Journal Japanese Association Dialysis Physicians 19(3):468–479

    Google Scholar 

  • Sugisaki, H., Ohta, Y., Ohira, S., Onoyama, T., Kuma, H., Suzuku, M., Yamakawa, T., Yoshida, T., Ono, T., Tozawa, S., Miyamoto, T., & Yamazaki, C. (2007). The 10t dialysis practice survey [in Japanese]. Journal of the Japanese Association of Dialysis Physicians, 21(2) (in press).

  • Suzuki M., Sugisaki H., Yoshida T., Yamazaki C. (2002). The 5t dialysis practice survey [in Japanese]. Journal of the Japanese Association of Dialysis Physicians 17(2):183–226

    Google Scholar 

  • Tsuji-Hayashi Y. Fukuhara S., Oshima S., Uchida K., Green J., Takai I., Maeda K. (1999). Health-related quality of life among renal transplant patients in Japan. Transplantation 68:1331–1335

    Article  Google Scholar 

  • World Bank (2005). 2005 World development indicators. Washington, D.C.: The World Bank Group.

  • World Health Organization (WHO) (2006). Annex table 1: basic indicators for all member states. In The World Health Report 2006: Working Together for Health. Geneva, Switzerland: World Health Organization. Retrieved September 18, 2006 at http://www.who.int/whr/2006/annex/en.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shunichi Fukuhara.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fukuhara, S., Yamazaki, C., Hayashino, Y. et al. The organization and financing of end-stage renal disease treatment in Japan. Int J Health Care Finance Econ 7, 217–231 (2007). https://doi.org/10.1007/s10754-007-9017-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10754-007-9017-8

Keywords

JEL Classifications

Navigation